Global eClinical Solutions Market Research Report Forecast to 2023

Array
(
    [id] => 1778687
    [discount] => PDF-18-ENTERPRISE WIDE LICENCE-20------
    [isbn] => 
    [title] => Global eClinical Solutions Market Research Report Forecast to 2023
    [upcommingtext] => 
    [seo_url] => global-eclinical-solutions-market-research-report-forecast
    [shortdesc] => 
    [meta_title] => Global eClinical Solutions Market Research Report Forecast to 2023
    [keyword] => Global eClinical Solutions Market Research Report Forecast to 2023
    [description] => Global eClinical Solutions Market: Information by Type (Clinical Data Management System (CDMS), Randomization and Trial Supply Management (RTSM), Electronic Clinical Outcome Assessment (eCOA), Clinical Trial Management System (CTMS), Electronic Trial
    [curr] => USD
    [category] => 1200
    [publisher] => 182
    [published_date] => 2019-08-01
    [country] => 230
    [author_name] => 
    [page_num] => 142
    [abstract] => Global eClinical Solutions Market: Information by Type (Clinical Data Management System (CDMS), Randomization and Trial Supply Management (RTSM), Electronic Clinical Outcome Assessment (eCOA), Clinical Trial Management System (CTMS), Electronic Trial Master Files (eTMF), Trial Safety & Regulatory), Delivery Mode (Web-Based and Cloud-Based, Enterprise-Based), Clinical Trial Phase (Phase I, Phase II and Others), End User (End user Contract Research Organizations (CROs), Pharma/Biotech Companies) and Region (North America, Europe, Asia-Pacific and RoW) - Forecast till 2023

Market analysis
To reach USD 9434.57 million by 2023, the Global eClinical Solutions Market is predictable to register a CAGR of 12.24% The eClinical solutions market is a combination of clinical technology and has the expertise which is used to recover the clinical development procedure through data management and data scrutiny. Main features describing the market progress are rising R&D events by biopharmaceutical and pharmaceutical corporations, mounting outflow on the expansion of clinical trials, increasing weight of chronic diseases, and amplified adoption of smart devices for healthcare management. The largest market share is of Americas 47.99% in 2017, and the regional market is expected to list a CAGR of 12.41 % during the forecast period. The US is one of the top markets in the region, accounting for the largest market share during the review period. However, the Canadian market is predictable to show the highest growth rate of 9.98% during the forecast period from 2018 to 2023. Cumulative outsourcing of clinical trials and availability of diverse patient population are the main drivers for market growth. The Asia-Pacific market is likely to show substantial growth during the forecast period. India is the fastest growing region owing to its large geriatric population, which is strivers the growth of the eClinical solutions market in the region. The main contributor to the growth of the regional market is Japan, followed by China. The Clinical Data Management System (CDMS) segment is expected to lead the market and register a substantial CAGR to reach USD 2579 million by the end of 2023. CDMS is considered to be the most important part of eClinical solutions. CDMS is a tool used in clinical research to manage and store the data of clinical trials. However, the electronic clinical outcome assessment (eCOA) segment is projected to exhibit the highest CAGR of 14.98% from 2018 to 2023. The increasing demand for electronic clinical outcome assessment is driving the growth of the segment. Envisioned Spectators are Investors and trade experts, Governments, associations, and industrial bodies, e Clinical solution providers, Healthcare, IT industry, Retailers, distributors, and wholesalers,
Market segmentation
Global eClinical Solutions Market is segmented into 3 segments.It is segmented by Delivery Mode i.e., Enterprise-Based and Web-Based and Cloud-Based. It is also segmented by Type wherein different types are Clinical Trial Management System (CTMS), Clinical Data Management System (CDMS), Electronic Clinical Outcome Assessment (eCOA), Electronic Trial Master Files (eTMF), Trial Safety & Regulatory Randomization and Trial Supply Management (RTSM). And one of the most important segments is by Region. In this Market segmentation is based on region. North America covering US, Canada, Mexico, Europe covering Germany, UK, France, Spain, Italy, Rest of Europe, Asia-Pacific covering China, India, Japan, Australia & New Zealand, Southeast Asia, Rest of Asia-Pacific and Rest of the World covering Middle East, Africa, Latin America



Regional Analysis
North America covering US, Canada, Mexico, Europe covering Germany, UK, France, Spain, Italy, Rest of Europe, Asia-Pacific covering China, India, Japan, Australia & New Zealand, Southeast Asia, Rest of Asia-Pacific and Rest of the World covering Middle East, Africa, Latin America

Key Players
The prominent players in the global eClinical solutions market are ERT Clinical, PAREXEL International Corporation, BioClinica, Inc., CRF Health, Oracle Corporation, DATATRAK International, Inc., Merge Healthcare Inc, Medidata Solutions, Inc., Omnicomm Systems, Inc. and MaxisIT.
The players operating in the global eClinical Solutions market are focusing on product launches, along with expanding their global footprints by entering untapped markets. [table_of_contents] =>

1 Executive Summary
1.1 Market Attractiveness Analysis
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Assumptions
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing R&D Activities by Biopharmaceutical and Pharmaceutical Companies
4.2.2 Growing Expenditure in The Development of Clinical Trials
4.2.3 Rising Burden of Chronic Diseases
4.2.4 Increased Use of Smart Devices for Healthcare Management
4.3 Restraints
4.3.1 Shortage of Healthcare Professionals and Patients for Clinical Trials
4.3.2 Security and Confidentiality of Data
4.4 Opportunities
4.4.1 Increasing R&D for Precision Medicine Will Strengthen the Market for eClinical Solutions
4.5 Mega Trends
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 Inputs
5.1.2 Software Development Process
5.1.3 Output
5.1.4 Marketing and Distribution
5.1.5 Post-Selling Services
5.2 Porter’s Five Forces Model
5.2.1 Threat of New Entrants
5.2.2 Bargaining Power of Suppliers
5.2.3 Bargaining Power of Buyers
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Regulatory Framework
6 Global eClinical Solutions Market, by Type
6.1 Introduction
6.2 Clinical Data Management System (CDMS)
6.3 Randomization and Trial Supply Management (RTSM)
6.4 Electronic Clinical Outcome Assessment (eCOA)
6.5 Clinical Trial Management System (CTMS)
6.6 Electronic Trail Master Files (eTMF)
6.7 Trial Safety & Regulatory
7 Global eClinical Solutions Market, by Delivery Mode
7.1 Introduction
7.2 Web Based and Cloud Based
7.3 Enterprise Based
8 Global eClinical Solutions Market, by Clinical Trial Phase
8.1 Introduction
8.2 Phase I
8.3 Phase II
8.4 Phase III
8.5 Phase IV
9 Global eClinical Solutions Market, by End User
9.1 Introduction
9.2 Contract Research Organizations (CROs)
9.3 Pharma/Biotech Companies
10 Global eClinical Solutions Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 Latin America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 UK
10.3.1.3 France
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
11 Competitive Landscape
11.1 Company Market Share Analysis
11.1.1 Introduction
12 Company Profiles
12.1 ERT Clinical
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products/Services Offered
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.1.6 Key Strategies
12.2 Parexel International Corporation
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products/Services Offered
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.2.6 Key Strategies
12.3 BioClinica, Inc.
12.3.1 Company Overview
12.3.2 Financial Overview
12.3.3 Products/Services Offered
12.3.4 Key Developments
12.3.5 SWOT Analysis
12.3.6 Key Strategies
12.4 CRF Health
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products/Services Offered
12.4.4 Key Developments
12.4.5 SWOT Analysis
12.4.6 Key Strategies
12.5 Oracle Corporation
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products/Services Offered
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.5.6 Key Strategies
12.6 Datatrak Int.
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products/Services Offered
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.6.6 Key Strategies
12.7 Merge Healthcare Inc.
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products/Services Offered
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.7.6 Key Strategies
12.8 Medidata Solutions, Inc.
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products/Services Offered
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.8.6 Key Strategies
12.9 Omnicomm Systems, Inc.
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products/Services Offered
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.9.6 Key Strategies
12.1 MaxisIT
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products Offering
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.10.6 Key Strategies
13 Appendix
13.1 References
13.2 Related Reports [list_of_tables] =>

TABLE 1 GLOBAL ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 2 GLOBAL ECLINICAL SOLUTIONS MARKET FOR CLINICAL DATA MANAGEMENT SYSTEM (CDMS), BY REGION, 2015–2023 (USD MILLION)
TABLE 3 GLOBAL ECLINICAL SOLUTIONS MARKET FOR RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM), BY REGION, 2015–2023 (USD MILLION)
TABLE 4 GLOBAL ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA), BY REGION, 2015–2023 (USD MILLION)
TABLE 5 GLOBAL ECLINICAL SOLUTIONS MARKET FOR CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS), BY REGION, 2015–2023 (USD MILLION)
TABLE 6 GLOBAL ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC TRAIL MASTER FILES (ETMF), BY REGION, 2015–2023 (USD MILLION)
TABLE 7 GLOBAL ECLINICAL SOLUTIONS MARKET FOR TRIAL SAFETY & REGULATORY, BY REGION, 2015–2023 (USD MILLION)
TABLE 8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 9 GLOBAL ECLINICAL SOLUTIONS MARKET FOR WEB BASED AND CLOUD BASED, BY REGION, 2015–2023 (USD MILLION)
TABLE 10 GLOBAL ECLINICAL SOLUTIONS MARKET FOR ENTERPRISE BASED, BY REGION, 2015–2023 (USD MILLION)
TABLE 11 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 12 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE I, BY REGION, 2015–2023 (USD MILLION)
TABLE 13 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE II, BY REGION, 2015–2023 (USD MILLION)
TABLE 14 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE III, BY REGION, 2015–2023 (USD MILLION)
TABLE 15 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE IV, BY REGION, 2015–2023 (USD MILLION)
TABLE 16 GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 17 GLOBAL ECLINICAL SOLUTIONS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2015–2023 (USD MILLION)
TABLE 18 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHARMA/BIOTECH COMPANIES, BY REGION, 2015–2023 (USD MILLION)
TABLE 19 GLOBAL ECLINICAL SOLUTIONS MARKET, BY REGION, 2015–2023 (USD MILLION)
TABLE 20 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY REGION, 2015–2023 (USD MILLION)
TABLE 21 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 22 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 23 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 24 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 25 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2015–2023 (USD MILLION)
TABLE 26 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 27 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 28 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 29 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 30 US: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 31 US: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 32 US: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 33 US: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 34 CANADA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 35 CANADA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 36 CANADA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 37 CANADA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 38 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 39 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 40 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 41 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 42 EUROPE: ECLINICAL SOLUTIONS MARKET, BY REGION, 2015–2023 (USD MILLION)
TABLE 43 EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION)
TABLE 44 EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 45 EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 46 EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION)
TABLE 47 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2015–2023 (USD MILLION)
TABLE 48 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION)
TABLE 49 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 50 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 51 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION)
TABLE 52 GERMANY: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION)
TABLE 53 GERMANY: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 54 GERMANY: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 55 GERMANY: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION)
TABLE 56 UK: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION)
TABLE 57 UK: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 58 UK: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 59 UK: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION)
TABLE 60 FRANCE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION)
TABLE 61 FRANCE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 62 FRANCE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 63 FRANCE: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION)
TABLE 64 ITALY: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION)
TABLE 65 ITALY: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 66 ITALY: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 67 ITALY: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION)
TABLE 68 SPAIN: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION)
TABLE 69 SPAIN: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 70 SPAIN: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 71 SPAIN: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION)
TABLE 72 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION)
TABLE 73 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 74 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 75 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION)
TABLE 76 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION)
TABLE 77 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 78 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 79 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION)
TABLE 80 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2015–2023 (USD MILLION)
TABLE 81 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 82 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 83 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 84 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 85 JAPAN: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 86 JAPAN: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 87 JAPAN: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 88 JAPAN: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 89 CHINA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 90 CHINA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 91 CHINA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 92 CHINA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 93 INDIA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 94 INDIA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 95 INDIA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 96 INDIA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 97 AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 98 AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 99 AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 100 AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 101 SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 102 SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 103 SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 104 SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 105 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015–2023 (USD MILLION)
TABLE 106 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 107 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 108 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015–2023 (USD MILLION)
TABLE 109 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET, BY REGION, 2015–2023 (USD MILLION)
TABLE 110 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION)
TABLE 111 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 112 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 113 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION)
TABLE 114 MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION)
TABLE 115 MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 116 MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 117 MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION)
TABLE 118 AFRICA: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015–2023 (USD MILLION)
TABLE 119 AFRICA: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015–2023 (USD MILLION)
TABLE 120 AFRICA: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015–2023 (USD MILLION)
TABLE 121 AFRICA: ECLINICAL SOLUTIONS MARKET BY END USER, 2015–2023 (USD MILLION) [list_of_figures] =>

FIGURE 1 MARKET SYNOPSIS
FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL ECLINICAL SOLUTIONS MARKET
FIGURE 3 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY TYPE, 2017 (%)
FIGURE 4 GLOBAL ECLINICAL SOLUTIONS MARKET, BY TYPE, 2016–2023 (USD MILLION)
FIGURE 5 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY DELIVERY MODE, 2017 (%)
FIGURE 6 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2016–2023 (USD MILLION)
FIGURE 7 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE, 2017 (%)
FIGURE 8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2016–2023 (USD MILLION)
FIGURE 9 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER, 2017 (%)
FIGURE 10 GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2016–2023 (USD MILLION)
FIGURE 11 GLOBAL ECLINICAL SOLUTIONS MARKET: MARKET STRUCTURE
FIGURE 12 RESEARCH PROCESS OF MRFR
FIGURE 13 TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 14 MARKET DYNAMICS: ANALYSIS OF GLOBAL ECLINICAL SOLUTIONS MARKET
FIGURE 15 VALUE CHAIN: GLOBAL ECLINICAL SOLUTIONS MARKET
FIGURE 16 PORTERS FIVE FORCES ANALYSIS OF THE GLOBAL ECLINICAL SOLUTIONS MARKET
FIGURE 17 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY TYPE, 2017(%)
FIGURE 18 GLOBAL ECLINICAL SOLUTIONS MARKET, BY TYPE, 2017 & 2023 (USD MILLION)
FIGURE 19 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY DELIVERY MODE, 2017 (%)
FIGURE 20 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2017 & 2023 (USD MILLION)
FIGURE 21 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE, 2017(%)
FIGURE 22 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017 & 2023 (USD MILLION)
FIGURE 23 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER, 2017(%)
FIGURE 24 GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2017 & 2023 (USD MILLION)
FIGURE 25 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017(%)
FIGURE 26 GLOBAL ECLINICAL SOLUTIONS MARKET, BY REGION, 2017 & 2023 (USD MILLION)
FIGURE 27 AMERICAS: ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 28 EUROPE: ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 29 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SHARE, BY COUNTRY, 2017 (%)
FIGURE 30 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 31 GLOBAL ECLINICAL SOLUTIONS MARKET, MARKET SHARE ANALYSIS, 2017 (% SHARE) [sample_page] => [brochure] => [new_price] => PDF-4450-ENTERPRISE WIDE LICENCE-6250-GLOBAL LICENCE--MULTI USER LICENCE--ENTERPRISE WIDE LICENCE--ENTERPRISE WIDE LICENCE--Multi User Licence- )
discount aarkstore
Global eClinical Solutions Market: Information by Type (Clinical Data Management System (CDMS), Randomization and Trial Supply Management (RTSM), Electronic Clinical Outcome Assessment (eCOA), Clinical Trial Management System (CTMS), Electronic Trial Master Files (eTMF), Trial Safety & Regulatory), Delivery Mode (Web-Based and Cloud-Based, Enterprise-Based), Clinical Trial Phase (Phase I, Phase II and Others), End User (End user Contract Research Organizations (CROs), Pharma/Biotech Companies) and Region (North America, Europe, Asia-Pacific and RoW) - Forecast till 2023

Market analysis
To reach USD 9434.57 million by 2023, the Global eClinical Solutions Market is predictable to register a CAGR of 12.24% The eClinical solutions market is a combination of clinical technology and has the expertise which is used to recover the clinical development procedure through data management and data scrutiny. Main features describing the market progress are rising R&D events by biopharmaceutical and pharmaceutical corporations, mounting outflow on the expansion of clinical trials, increasing weight of chronic diseases, and amplified adoption of smart devices for healthcare management. The largest market share is of Americas 47.99% in 2017, and the regional market is expected to list a CAGR of 12.41 % during the forecast period. The US is one of the top markets in the region, accounting for the largest market share during the review period. However, the Canadian market is predictable to show the highest growth rate of 9.98% during the forecast period from 2018 to 2023. Cumulative outsourcing of clinical trials and availability of diverse patient population are the main drivers for market growth. The Asia-Pacific market is likely to show substantial growth during the forecast period. India is the fastest growing region owing to its large geriatric population, which is strivers the growth of the eClinical solutions market in the region. The main contributor to the growth of the regional market is Japan, followed by China. The Clinical Data Management System (CDMS) segment is expected to lead the market and register a substantial CAGR to reach USD 2579 million by the end of 2023. CDMS is considered to be the most important part of eClinical solutions. CDMS is a tool used in clinical research to manage and store the data of clinical trials. However, the electronic clinical outcome assessment (eCOA) segment is projected to exhibit the highest CAGR of 14.98% from 2018 to 2023. The increasing demand for electronic clinical outcome assessment is driving the growth of the segment. Envisioned Spectators are Investors and trade experts, Governments, associations, and industrial bodies, e Clinical solution providers, Healthcare, IT industry, Retailers, distributors, and wholesalers,
Market segmentation
Global eClinical Solutions Market is segmented into 3 segments.It is segmented by Delivery Mode i.e., Enterprise-Based and Web-Based and Cloud-Based. It is also segmented by Type wherein different types are Clinical Trial Management System (CTMS), Clinical Data Management System (CDMS), Electronic Clinical Outcome Assessment (eCOA), Electronic Trial Master Files (eTMF), Trial Safety & Regulatory Randomization and Trial Supply Management (RTSM). And one of the most important segments is by Region. In this Market segmentation is based on region. North America covering US, Canada, Mexico, Europe covering Germany, UK, France, Spain, Italy, Rest of Europe, Asia-Pacific covering China, India, Japan, Australia & New Zealand, Southeast Asia, Rest of Asia-Pacific and Rest of the World covering Middle East, Africa, Latin America



Regional Analysis
North America covering US, Canada, Mexico, Europe covering Germany, UK, France, Spain, Italy, Rest of Europe, Asia-Pacific covering China, India, Japan, Australia & New Zealand, Southeast Asia, Rest of Asia-Pacific and Rest of the World covering Middle East, Africa, Latin America

Key Players
The prominent players in the global eClinical solutions market are ERT Clinical, PAREXEL International Corporation, BioClinica, Inc., CRF Health, Oracle Corporation, DATATRAK International, Inc., Merge Healthcare Inc, Medidata Solutions, Inc., Omnicomm Systems, Inc. and MaxisIT.
The players operating in the global eClinical Solutions market are focusing on product launches, along with expanding their global footprints by entering untapped markets.


1Executive Summary
1.1Market Attractiveness Analysis
2Market Introduction
2.1Definition
2.2Scope of the Study
2.3Assumptions
2.4Market Structure
3Research Methodology
3.1Research Process
3.2Primary Research
3.3Secondary Research
3.4Market Size Estimation
3.5Forecast Model
4Market Dynamics
4.1Introduction
4.2Drivers
4.2.1Increasing R&D Activities by Biopharmaceutical and Pharmaceutical Companies
4.2.2Growing Expenditure in The Development of Clinical Trials
4.2.3Rising Burden of Chronic Diseases
4.2.4Increased Use of Smart Devices for Healthcare Management
4.3Restraints
4.3.1Shortage of Healthcare Professionals and Patients for Clinical Trials
4.3.2Security and Confidentiality of Data
4.4Opportunities
4.4.1Increasing R&D for Precision Medicine Will Strengthen the Market for eClinical Solutions
4.5Mega Trends
5Market Factor Analysis
5.1Value Chain Analysis
5.1.1Inputs
5.1.2Software Development Process
5.1.3Output
5.1.4Marketing and Distribution
5.1.5Post-Selling Services
5.2Porters Five Forces Model
5.2.1Threat of New Entrants
5.2.2Bargaining Power of Suppliers
5.2.3Bargaining Power of Buyers
5.2.4Threat of Substitutes
5.2.5Intensity of Rivalry
5.3Regulatory Framework
6Global eClinical Solutions Market, by Type
6.1Introduction
6.2Clinical Data Management System (CDMS)
6.3Randomization and Trial Supply Management (RTSM)
6.4Electronic Clinical Outcome Assessment (eCOA)
6.5Clinical Trial Management System (CTMS)
6.6Electronic Trail Master Files (eTMF)
6.7Trial Safety & Regulatory
7Global eClinical Solutions Market, by Delivery Mode
7.1Introduction
7.2Web Based and Cloud Based
7.3Enterprise Based
8Global eClinical Solutions Market, by Clinical Trial Phase
8.1Introduction
8.2Phase I
8.3Phase II
8.4Phase III
8.5Phase IV
9Global eClinical Solutions Market, by End User
9.1Introduction
9.2Contract Research Organizations (CROs)
9.3Pharma/Biotech Companies
10Global eClinical Solutions Market, by Region
10.1Introduction
10.2Americas
10.2.1North America
10.2.1.1US
10.2.1.2Canada
10.2.2Latin America
10.3Europe
10.3.1Western Europe
10.3.1.1Germany
10.3.1.2UK
10.3.1.3France
10.3.1.4Italy
10.3.1.5Spain
10.3.1.6Rest of Western Europe
10.3.2Eastern Europe
10.4Asia-Pacific
10.4.1Japan
10.4.2China
10.4.3India
10.4.4Australia
10.4.5South Korea
10.4.6Rest of Asia-Pacific
10.5Middle East & Africa
10.5.1Middle East
10.5.2Africa
11Competitive Landscape
11.1Company Market Share Analysis
11.1.1Introduction
12Company Profiles
12.1ERT Clinical
12.1.1Company Overview
12.1.2Financial Overview
12.1.3Products/Services Offered
12.1.4Key Developments
12.1.5SWOT Analysis
12.1.6Key Strategies
12.2Parexel International Corporation
12.2.1Company Overview
12.2.2Financial Overview
12.2.3Products/Services Offered
12.2.4Key Developments
12.2.5SWOT Analysis
12.2.6Key Strategies
12.3BioClinica, Inc.
12.3.1Company Overview
12.3.2Financial Overview
12.3.3Products/Services Offered
12.3.4Key Developments
12.3.5SWOT Analysis
12.3.6Key Strategies
12.4CRF Health
12.4.1Company Overview
12.4.2Financial Overview
12.4.3Products/Services Offered
12.4.4Key Developments
12.4.5SWOT Analysis
12.4.6Key Strategies
12.5Oracle Corporation
12.5.1Company Overview
12.5.2Financial Overview
12.5.3Products/Services Offered
12.5.4Key Developments
12.5.5SWOT Analysis
12.5.6Key Strategies
12.6Datatrak Int.
12.6.1Company Overview
12.6.2Financial Overview
12.6.3Products/Services Offered
12.6.4Key Developments
12.6.5SWOT Analysis
12.6.6Key Strategies
12.7Merge Healthcare Inc.
12.7.1Company Overview
12.7.2Financial Overview
12.7.3Products/Services Offered
12.7.4Key Developments
12.7.5SWOT Analysis
12.7.6Key Strategies
12.8Medidata Solutions, Inc.
12.8.1Company Overview
12.8.2Financial Overview
12.8.3Products/Services Offered
12.8.4Key Developments
12.8.5SWOT Analysis
12.8.6Key Strategies
12.9Omnicomm Systems, Inc.
12.9.1Company Overview
12.9.2Financial Overview
12.9.3Products/Services Offered
12.9.4Key Developments
12.9.5SWOT Analysis
12.9.6Key Strategies
12.1MaxisIT
12.10.1Company Overview
12.10.2Financial Overview
12.10.3Products Offering
12.10.4Key Developments
12.10.5SWOT Analysis
12.10.6Key Strategies
13Appendix
13.1References
13.2Related Reports

List Of Tables



TABLE 1GLOBAL ECLINICAL SOLUTIONS MARKET, BY TYPE, 20152023 (USD MILLION)
TABLE 2GLOBAL ECLINICAL SOLUTIONS MARKET FOR CLINICAL DATA MANAGEMENT SYSTEM (CDMS), BY REGION, 20152023 (USD MILLION)
TABLE 3GLOBAL ECLINICAL SOLUTIONS MARKET FOR RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM), BY REGION, 20152023 (USD MILLION)
TABLE 4GLOBAL ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA), BY REGION, 20152023 (USD MILLION)
TABLE 5GLOBAL ECLINICAL SOLUTIONS MARKET FOR CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS), BY REGION, 20152023 (USD MILLION)
TABLE 6GLOBAL ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC TRAIL MASTER FILES (ETMF), BY REGION, 20152023 (USD MILLION)
TABLE 7GLOBAL ECLINICAL SOLUTIONS MARKET FOR TRIAL SAFETY & REGULATORY, BY REGION, 20152023 (USD MILLION)
TABLE 8GLOBAL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 9GLOBAL ECLINICAL SOLUTIONS MARKET FOR WEB BASED AND CLOUD BASED, BY REGION, 20152023 (USD MILLION)
TABLE 10GLOBAL ECLINICAL SOLUTIONS MARKET FOR ENTERPRISE BASED, BY REGION, 20152023 (USD MILLION)
TABLE 11GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 12GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE I, BY REGION, 20152023 (USD MILLION)
TABLE 13GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE II, BY REGION, 20152023 (USD MILLION)
TABLE 14GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE III, BY REGION, 20152023 (USD MILLION)
TABLE 15GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE IV, BY REGION, 20152023 (USD MILLION)
TABLE 16GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 17GLOBAL ECLINICAL SOLUTIONS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 20152023 (USD MILLION)
TABLE 18GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHARMA/BIOTECH COMPANIES, BY REGION, 20152023 (USD MILLION)
TABLE 19GLOBAL ECLINICAL SOLUTIONS MARKET, BY REGION, 20152023 (USD MILLION)
TABLE 20AMERICAS: ECLINICAL SOLUTIONS MARKET, BY REGION, 20152023 (USD MILLION)
TABLE 21AMERICAS: ECLINICAL SOLUTIONS MARKET, BY TYPE, 20152023 (USD MILLION)
TABLE 22AMERICAS: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 23AMERICAS: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 24AMERICAS: ECLINICAL SOLUTIONS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 25NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 20152023 (USD MILLION)
TABLE 26NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 20152023 (USD MILLION)
TABLE 27NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 28NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 29NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 30US: ECLINICAL SOLUTIONS MARKET, BY TYPE, 20152023 (USD MILLION)
TABLE 31US: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 32US: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 33US: ECLINICAL SOLUTIONS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 34CANADA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 20152023 (USD MILLION)
TABLE 35CANADA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 36CANADA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 37CANADA: ECLINICAL SOLUTIONS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 38LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 20152023 (USD MILLION)
TABLE 39LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 40LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 41LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 42EUROPE: ECLINICAL SOLUTIONS MARKET, BY REGION, 20152023 (USD MILLION)
TABLE 43EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 20152023 (USD MILLION)
TABLE 44EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 45EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 46EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 20152023 (USD MILLION)
TABLE 47WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 20152023 (USD MILLION)
TABLE 48WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 20152023 (USD MILLION)
TABLE 49WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 50WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 51WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 20152023 (USD MILLION)
TABLE 52GERMANY: ECLINICAL SOLUTIONS MARKET BY TYPE, 20152023 (USD MILLION)
TABLE 53GERMANY: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 54GERMANY: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 55GERMANY: ECLINICAL SOLUTIONS MARKET BY END USER, 20152023 (USD MILLION)
TABLE 56UK: ECLINICAL SOLUTIONS MARKET BY TYPE, 20152023 (USD MILLION)
TABLE 57UK: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 58UK: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 59UK: ECLINICAL SOLUTIONS MARKET BY END USER, 20152023 (USD MILLION)
TABLE 60FRANCE: ECLINICAL SOLUTIONS MARKET BY TYPE, 20152023 (USD MILLION)
TABLE 61FRANCE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 62FRANCE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 63FRANCE: ECLINICAL SOLUTIONS MARKET BY END USER, 20152023 (USD MILLION)
TABLE 64ITALY: ECLINICAL SOLUTIONS MARKET BY TYPE, 20152023 (USD MILLION)
TABLE 65ITALY: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 66ITALY: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 67ITALY: ECLINICAL SOLUTIONS MARKET BY END USER, 20152023 (USD MILLION)
TABLE 68SPAIN: ECLINICAL SOLUTIONS MARKET BY TYPE, 20152023 (USD MILLION)
TABLE 69SPAIN: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 70SPAIN: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 71SPAIN: ECLINICAL SOLUTIONS MARKET BY END USER, 20152023 (USD MILLION)
TABLE 72REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 20152023 (USD MILLION)
TABLE 73REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 74REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 75REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 20152023 (USD MILLION)
TABLE 76EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 20152023 (USD MILLION)
TABLE 77EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 78EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 79EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 20152023 (USD MILLION)
TABLE 80ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 20152023 (USD MILLION)
TABLE 81ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY TYPE, 20152023 (USD MILLION)
TABLE 82ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 83ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 84ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 85JAPAN: ECLINICAL SOLUTIONS MARKET, BY TYPE, 20152023 (USD MILLION)
TABLE 86JAPAN: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 87JAPAN: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 88JAPAN: ECLINICAL SOLUTIONS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 89CHINA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 20152023 (USD MILLION)
TABLE 90CHINA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 91CHINA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 92CHINA: ECLINICAL SOLUTIONS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 93INDIA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 20152023 (USD MILLION)
TABLE 94INDIA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 95INDIA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 96INDIA: ECLINICAL SOLUTIONS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 97AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 20152023 (USD MILLION)
TABLE 98AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 99AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 100AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 101SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 20152023 (USD MILLION)
TABLE 102SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 103SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 104SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 105REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY TYPE, 20152023 (USD MILLION)
TABLE 106REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 107REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 108REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY END USER, 20152023 (USD MILLION)
TABLE 109MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET, BY REGION, 20152023 (USD MILLION)
TABLE 110MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY TYPE, 20152023 (USD MILLION)
TABLE 111MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 112MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 113MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY END USER, 20152023 (USD MILLION)
TABLE 114MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY TYPE, 20152023 (USD MILLION)
TABLE 115MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 116MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 117MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY END USER, 20152023 (USD MILLION)
TABLE 118AFRICA: ECLINICAL SOLUTIONS MARKET BY TYPE, 20152023 (USD MILLION)
TABLE 119AFRICA: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 20152023 (USD MILLION)
TABLE 120AFRICA: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 20152023 (USD MILLION)
TABLE 121AFRICA: ECLINICAL SOLUTIONS MARKET BY END USER, 20152023 (USD MILLION)

List Of Figures



FIGURE 1MARKET SYNOPSIS
FIGURE 2MARKET ATTRACTIVENESS ANALYSIS: GLOBAL ECLINICAL SOLUTIONS MARKET
FIGURE 3GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY TYPE, 2017 (%)
FIGURE 4GLOBAL ECLINICAL SOLUTIONS MARKET, BY TYPE, 20162023 (USD MILLION)
FIGURE 5GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY DELIVERY MODE, 2017 (%)
FIGURE 6GLOBAL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 20162023 (USD MILLION)
FIGURE 7GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE, 2017 (%)
FIGURE 8GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 20162023 (USD MILLION)
FIGURE 9GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER, 2017 (%)
FIGURE 10GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 20162023 (USD MILLION)
FIGURE 11GLOBAL ECLINICAL SOLUTIONS MARKET: MARKET STRUCTURE
FIGURE 12RESEARCH PROCESS OF MRFR
FIGURE 13TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 14MARKET DYNAMICS: ANALYSIS OF GLOBAL ECLINICAL SOLUTIONS MARKET
FIGURE 15VALUE CHAIN: GLOBAL ECLINICAL SOLUTIONS MARKET
FIGURE 16PORTERS FIVE FORCES ANALYSIS OF THE GLOBAL ECLINICAL SOLUTIONS MARKET
FIGURE 17GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY TYPE, 2017(%)
FIGURE 18GLOBAL ECLINICAL SOLUTIONS MARKET, BY TYPE, 2017 & 2023 (USD MILLION)
FIGURE 19GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY DELIVERY MODE, 2017 (%)
FIGURE 20GLOBAL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2017 & 2023 (USD MILLION)
FIGURE 21GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE, 2017(%)
FIGURE 22GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017 & 2023 (USD MILLION)
FIGURE 23GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER, 2017(%)
FIGURE 24GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2017 & 2023 (USD MILLION)
FIGURE 25GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017(%)
FIGURE 26GLOBAL ECLINICAL SOLUTIONS MARKET, BY REGION, 2017 & 2023 (USD MILLION)
FIGURE 27AMERICAS: ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 28EUROPE: ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 29ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SHARE, BY COUNTRY, 2017 (%)
FIGURE 30MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 31GLOBAL ECLINICAL SOLUTIONS MARKET, MARKET SHARE ANALYSIS, 2017 (% SHARE)

2020 Global Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Americas, EMEA, APAC--A 68-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

This new 68-country report is available by region, country, market segment, section, or individual test. The report is designed to help current suppliers and potential market entrants identify and

USD 45000 View Report

Global Estrogen Replacement Therapy Market by Dosage Forms (Patches, Tablets, Gels/Creams, Suppositories, Implants And Injections), By Routes Of Administration (Oral, Topical, Subcutaneous Pellets, Injections, and Others), By End-User (Hospitals, Clinics, Pharmacy Store, and Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast from 2020 to 2027

Global Estrogen Replacement Therapy Market by Dosage Forms (Patches, Tablets, Gels/Creams, Suppositories, Implants And Injections), By Routes Of Administration (Oral, Topical, Subcutaneous Pellets, Injections, and Others), By End-User (Hospitals, Clinics, Pharmacy Store, and Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast from 2020 to 2027 market research report available in single user pdf license with Aarkstore Enterprise at USD 4950

USD 4950 View Report

eClinical Solutions Market Size, Outlook and Growth Opportunities, 2019- 2025

Global eClinical Solutions Market Size, Outlook and Growth Opportunities to 2025: By Product (Electronic clinical outcome assessment (ECOA), Electronic data capture (EDC) & clinical data management systems (CDMS), Clinical analytics

USD 4580 View Report

Global eClinical Solutions Market

eClinical is a term used in a clinical study for electronic applications that are web-based tools used to collect live data from clinical trials.eClinical Solutions brings together clinical technology and

USD 3850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available